Optibrium, a developer of software for drug discovery, has announced a collaboration to provide StarDrop users with easy access to EnamineStore, a database of their commercially available screening compounds and chemical building blocks
Enamine, a chemical research organisation and TBD Biodiscovery, a GMP manufacturer of fine chemicals have announced a collaboration agreement to manage the transition of chemical synthesis of novel intermediates from laboratory to bulk scale under GMP standards
Enamine, a chemical research organisation and producer of the world’s largest collections of novel building blocks (150,000) and screening compound libraries (2,400,000), and BioSolveIT, premium provider of medicinal chemistry software, have announced the launch of the ‘REAL Space Navigator’
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
